Adagio Medical Holdings (ADGM) Cash from Investing Activities (2023 - 2026)
Adagio Medical Holdings (ADGM) reported Cash from Investing Activities of -$2000.0 for Q1 2026, up 99.4% on a YoY basis from -$1003.0 in Q1 2025, and down 100.41% sequentially from $491000.0 in Q4 2025.
Adagio Medical Holdings (ADGM) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Adagio Medical Holdings (ADGM) has 4 years of Cash from Investing Activities data on file, last reported at -$2000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Investing Activities rose 99.4% year-over-year to -$2000.0; the trailing twelve-month figure through Mar 2026 stood at -$424000.0 (up 60.63% YoY), and the FY2025 full-year result was -$374000.0, up 70.78% from the prior year.
- Cash from Investing Activities eased to -$2000.0 in Q1 2026, from $491000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $491000.0 in Q4 2025 to a low of -$578000.0 in Q3 2024.
- A 4-year average of -$86857.1 and a median of -$20000.0 in 2023 frame the typical range for Cash from Investing Activities.
- Across the five-year window, Cash from Investing Activities tumbled 106.79% in 2025 and jumped 99.4% in 2026, its largest moves.
- Tracing ADGM's Cash from Investing Activities over 4 years: stood at -$20000.0 in 2023, then sank by 2790.0% to -$578000.0 in 2024, then soared by 184.95% to $491000.0 in 2025, then plunged by 100.41% to -$2000.0 in 2026.
- Business Quant data shows ADGM's Cash from Investing Activities at -$2000.0 in Q1 2026, $491000.0 in Q4 2025, and -$335000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | Adagio Medical Holdings | 21.36 Mn | 21.36 Mn | - | -2,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,000.00 |
| Mar 31, 2026 | -2,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Dec 31, 2025 | 491,000.00 |
| Mar 31, 2025 | -335,000.00 |
| Mar 31, 2025 | -335,000.00 |
| Sep 30, 2024 | -578,000.00 |
| Sep 30, 2024 | -578,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -162,000.00 |
| Mar 31, 2024 | -162,000.00 |
| Dec 31, 2023 | -20,000.00 |
| Dec 31, 2023 | -20,000.00 |